Write your message
Volume 23 - Special Issue on COVID-19                   J Arak Uni Med Sci 2020, 23 - Special Issue on COVID-19: 0-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Agharezaee N, Forouzesh F. SARS-COV-2: History, Genetics, and Treatment. J Arak Uni Med Sci. 2020; 23
URL: http://jams.arakmu.ac.ir/article-1-6343-en.html
1- Department of Genetics, Faculty of Advanced Science and Technologies, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
2- Department of Genetics, Faculty of Advanced Science and Technologies, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran , f8forouzesh@gmail.com
Abstract:   (227 Views)
Background and Aim: Coronaviruses are a large family of viruses that cause disease in humans and animals. Covid-19 is an acute respiratory infectious disease caused by a new coronavirus. The World Health Organization (WHO) has declared the infection a pandemic (global epidemic).
Objective:  The aim of this study is to investigate the latest research advances in genetics, disease, clinical features of Covid-19, as well as current therapies and scientific advances to combat this dangerous global epidemic.
Materials and Methods: The present paper is a review study developed using electronic sources in reputable databases such as PubMed, Scopus, Google Scholar, ISI, and Science Direct from 2010 to 2020.
Findings: Examining the genome and genetic studies of the virus, there are many similarities with members of the coronavirus family, but there are differences in their genomic and phenotypic structures that can affect their pathogenesis.
Re-use of existing therapeutic drugs, previously designed for other infections and pathologies of viruses, is only a practical approach as a quick measure to respond to and fight the emerging epidemic. At present, tests for specific vaccines for the SARS-CoV-2 genome and the therapeutic antibodies being tested require a long-term process and require complete safety testing.
Ethical Considerations: Ethical principles in writing this study have been observed in accordance with the guidelines of the National Ethics Committee and the COPE regulations.
Conclusion: Rapid diagnosis of SARS-CoV-2 infection is the basis of disease control. So far, there is no specific antiviral drug approved for SARS-CoV-2 infection. Therefore, preventive and inactive measures against the virus are necessary to stop and control the spread of the disease, according to genetic studies and the achievement of molecular mechanisms of virus function in pathogenesis.
Full-Text [PDF 3728 kb]   (272 Downloads)    
Type of Study: Review Article | Subject: COVID-19
Received: 2020/05/30 | Accepted: 2020/07/28

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb